https://www.alphaview.kr 실시간 미국 주식 뉴스를 AI로 분석하여 시장 정보를 제공합니다. ko Sun, 25 Oct 2026 05:23:45 GMT https://www.alphaview.kr/images/brand/logo.png https://www.alphaview.kr Copyright 2026 AlphaView. All rights reserved. contact@alphaview.kr (AlphaView) contact@alphaview.kr (AlphaView) 30 https://www.alphaview.kr/news/83943-루닛과-서밋테라퓨틱스-면역종양학-개발에서-종양미세환경-분석을-위한-ai-기반-scope-io-플랫폼-적용-협약-체결 Sat, 24 Oct 2026 01:27:26 GMT https://www.alphaview.kr/news/83943-루닛과-서밋테라퓨틱스-면역종양학-개발에서-종양미세환경-분석을-위한-ai-기반-scope-io-플랫폼-적용-협약-체결 바이오/헬스케어 prnewswire PR Newswire https://www.alphaview.kr/news/79497-akeso-summit-therapeutics-및-ecog-acrin과-1차-치료-담도암-대상-이반투주맙-23상-임상-협력-발표 Wed, 21 Oct 2026 12:42:00 GMT https://www.alphaview.kr/news/79497-akeso-summit-therapeutics-및-ecog-acrin과-1차-치료-담도암-대상-이반투주맙-23상-임상-협력-발표 바이오/헬스케어 prnewswire PR Newswire https://www.alphaview.kr/news/11384-summit-therapeutics-예정된-투자자-컨퍼런스에서-발표-예정 Thu, 26 Feb 2026 23:45:00 GMT https://www.alphaview.kr/news/11384-summit-therapeutics-예정된-투자자-컨퍼런스에서-발표-예정 금융/자금조달 businesswire Business Wire https://www.alphaview.kr/news/10404-summit-therapeutics-2025년-4분기-및-연간-재무-결과-및-운영-진행-상황-보고 Mon, 23 Feb 2026 21:17:10 GMT https://www.alphaview.kr/news/10404-summit-therapeutics-2025년-4분기-및-연간-재무-결과-및-운영-진행-상황-보고 바이오/헬스케어 businesswire Business Wire https://www.alphaview.kr/news/4329-summit-therapeutics-2025년-4분기-및-연간-재무-결과-및-운영-현황-발표를-위한-통화-2026년-2월-23일-개최 Tue, 17 Feb 2026 22:18:30 GMT https://www.alphaview.kr/news/4329-summit-therapeutics-2025년-4분기-및-연간-재무-결과-및-운영-현황-발표를-위한-통화-2026년-2월-23일-개최 바이오/헬스케어 businesswire Business Wire https://www.alphaview.kr/news/72264-summit-therapeutics-nasdaq-상장-규정-5635c4에-따른-유인-부여-보고 Sat, 10 Jan 2026 01:16:00 GMT https://www.alphaview.kr/news/72264-summit-therapeutics-nasdaq-상장-규정-5635c4에-따른-유인-부여-보고 바이오/헬스케어 businesswire Business Wire